These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 30779865)

  • 1. Modification with CREKA Improves Cell Retention in a Rat Model of Myocardial Ischemia Reperfusion.
    Chen J; Song Y; Huang Z; Zhang N; Xie X; Liu X; Yang H; Wang Q; Li M; Li Q; Gong H; Qian J; Pang Z; Ge J
    Stem Cells; 2019 May; 37(5):663-676. PubMed ID: 30779865
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeted delivery of thymosin beta 4 to the injured myocardium using CREKA-conjugated nanoparticles.
    Huang Z; Song Y; Pang Z; Zhang B; Yang H; Shi H; Chen J; Gong H; Qian J; Ge J
    Int J Nanomedicine; 2017; 12():3023-3036. PubMed ID: 28442910
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polyethylene glycol-polylactic acid nanoparticles modified with cysteine-arginine-glutamic acid-lysine-alanine fibrin-homing peptide for glioblastoma therapy by enhanced retention effect.
    Wu J; Zhao J; Zhang B; Qian Y; Gao H; Yu Y; Wei Y; Yang Z; Jiang X; Pang Z
    Int J Nanomedicine; 2014; 9():5261-71. PubMed ID: 25419130
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modification of adipose mesenchymal stem cells-derived small extracellular vesicles with fibrin-targeting peptide CREKA for enhanced bone repair.
    Wu Q; Fu X; Li X; Li J; Han W; Wang Y
    Bioact Mater; 2023 Feb; 20():208-220. PubMed ID: 35702606
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CREKA peptide-conjugated dendrimer nanoparticles for glioblastoma multiforme delivery.
    Zhao J; Zhang B; Shen S; Chen J; Zhang Q; Jiang X; Pang Z
    J Colloid Interface Sci; 2015 Jul; 450():396-403. PubMed ID: 25863222
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gene-modified Mesenchymal Stem Cell-based Therapy in Renal Ischemia- Reperfusion Injury.
    Xu H; Chen C; Hu L; Hou J
    Curr Gene Ther; 2017; 17(6):453-460. PubMed ID: 29446737
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fibrin-targeting delivery: a novel platform for cardiac regenerative medicine.
    Huang Z; Song Y; Pang Z; Li M; Guliya Y; Shen Y; Qian J; Ge J
    J Cell Mol Med; 2016 Dec; 20(12):2410-2413. PubMed ID: 27469290
    [No Abstract]   [Full Text] [Related]  

  • 8. Targeted Delivery of Interferon Gamma Using a Recombinant Fusion Protein of a Fibrin Clot-Binding Peptide With Interferon Gamma for Cancer Gene Therapy.
    Ando M; Fujimoto M; Takahashi Y; Nishikawa M; Hamana A; Takakura Y
    J Pharm Sci; 2017 Mar; 106(3):892-897. PubMed ID: 27939375
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Photoacoustic Imaging of Myocardial Infarction Region Using Non-Invasive Fibrin-Targeted Nanoparticles in a Rat Myocardial Ischemia-Reperfusion Model.
    Zhang Y; Chen X; Liu L; Tian J; Hao L; Ran HT
    Int J Nanomedicine; 2021; 16():1331-1344. PubMed ID: 33628023
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intrathecally Transplanting Mesenchymal Stem Cells (MSCs) Activates ERK1/2 in Spinal Cords of Ischemia-Reperfusion Injury Rats and Improves Nerve Function.
    Wang Y; Liu H; Ma H
    Med Sci Monit; 2016 May; 22():1472-9. PubMed ID: 27135658
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intravenous Anesthetics Enhance the Ability of Human Bone Marrow-Derived Mesenchymal Stem Cells to Alleviate Hepatic Ischemia-Reperfusion Injury in a Receptor-Dependent Manner.
    Feng J; Yao W; Zhang Y; Xiang AP; Yuan D; Hei Z
    Cell Physiol Biochem; 2018; 47(2):556-566. PubMed ID: 29794450
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A rodent model of myocardial infarction for testing the efficacy of cells and polymers for myocardial reconstruction.
    Huang NF; Sievers RE; Park JS; Fang Q; Li S; Lee RJ
    Nat Protoc; 2006; 1(3):1596-609. PubMed ID: 17406452
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Focused ultrasound-induced stimulation of microbubbles augments site-targeted engraftment of mesenchymal stem cells after acute myocardial infarction.
    Ghanem A; Steingen C; Brenig F; Funcke F; Bai ZY; Hall C; Chin CT; Nickenig G; Bloch W; Tiemann K
    J Mol Cell Cardiol; 2009 Sep; 47(3):411-8. PubMed ID: 19540842
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Homing and differentiation of mesenchymal stem cells delivered intravenously to ischemic myocardium in vivo: a time-series study.
    Jiang W; Ma A; Wang T; Han K; Liu Y; Zhang Y; Dong A; Du Y; Huang X; Wang J; Lei X; Zheng X
    Pflugers Arch; 2006 Oct; 453(1):43-52. PubMed ID: 16915405
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Maximum efficacy of mesenchymal stem cells in rat model of renal ischemia-reperfusion injury: renal artery administration with optimal numbers.
    Cai J; Yu X; Xu R; Fang Y; Qian X; Liu S; Teng J; Ding X
    PLoS One; 2014; 9(3):e92347. PubMed ID: 24637784
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transforming growth factor-β1 promotes homing of bone marrow mesenchymal stem cells in renal ischemia-reperfusion injury.
    Si X; Liu X; Li J; Wu X
    Int J Clin Exp Pathol; 2015; 8(10):12368-78. PubMed ID: 26722423
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting cancer cells via tumor-homing peptide CREKA functional PEG nanoparticles.
    Okur AC; Erkoc P; Kizilel S
    Colloids Surf B Biointerfaces; 2016 Nov; 147():191-200. PubMed ID: 27513587
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fibrin-binding, peptide amphiphile micelles for targeting glioblastoma.
    Chung EJ; Cheng Y; Morshed R; Nord K; Han Y; Wegscheid ML; Auffinger B; Wainwright DA; Lesniak MS; Tirrell MV
    Biomaterials; 2014 Jan; 35(4):1249-56. PubMed ID: 24211079
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nanozyme Impregnated Mesenchymal Stem Cells for Hepatic Ischemia-Reperfusion Injury Alleviation.
    Sahu A; Jeon J; Lee MS; Yang HS; Tae G
    ACS Appl Mater Interfaces; 2021 Jun; 13(22):25649-25662. PubMed ID: 33974389
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preconditioning mesenchymal stem cells with transforming growth factor-alpha improves mesenchymal stem cell-mediated cardioprotection.
    Herrmann JL; Wang Y; Abarbanell AM; Weil BR; Tan J; Meldrum DR
    Shock; 2010 Jan; 33(1):24-30. PubMed ID: 19996917
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.